CoChat

GH Replacement Improves Quality of Life and Metabolic Parameters in Cured Acromegalic Patients with Growth Hormone Deficiency

The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.

Abstract

Objective Effects of GH replacement in patients with GH deficiency (GHD) after a cure for acromegaly so far have been poorly studied, although its prevalence among acromegalic patients may reach the 60%. The aim of the study was to evaluate whether metabolic parameters and quality of life are improved by GH replacement in patients with prior acromegaly and severe GHD. Design and methods This was a prospective study on 42 GHD subjects [22 men, mean age (sd): 48 ± 10]: 10 acromegalics treated with recombinant human GH (group A), 12 acromegalics who refused treatment (group B), and 20 subjects operated for nonfunctioning pituitary adenoma on recombinant human GH (group C). Serum IGF-I levels, lipid profile, glucose levels (fasting and after an oral glucose tolerance test), glycosylated hemoglobin, insulin resistance (homeostasis model assessment insulin resistance index), anthropometric parameters (body mass index, waist circumference, body composition), and quality of life (Questions on Life Satisfaction-Hypopituitarism Z-scores) were evaluated at baseline and after 12 and 36 months. Results At baseline, group B showed higher IGF sd score than group A and C, as well as better quality of life and higher post-oral glucose tolerance test glucose levels than group A. After 12-months, similarly in group A and C, the IGF-I sd score significantly increased, and body composition and lipid profile improved, without deterioration of glucose tolerance. Quality of life significantly improv…

Overview

Integrity signals

Registry

Crossref · 10.1210/jc.2012-2477

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 23 references

Cited by

See all 25

Metadata

Authors
Giavoli, C., Profka, E., Verrua, E., Ronchi, C. L., Ferrante, E., Bergamaschi, S., Sala, E., Malchiodi, E., Lania, A. G., Arosio, M., Ambrosi, B., Spada, A., & Beck-Peccoz, P.
Affiliations
  • University of Milan (IT)
  • Universitätsklinikum Würzburg (DE)
  • Department of Clinical Sciences and Community Health (C.G., E.P., E.V., E.F., S.B., E.S., E.M., M.A., A.S., P.B.-P.), University of Milan,
Corresponding author
Giavoli, Claudia
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2012-11-01
Volume
97
Issue
11
Pages
3983-3988
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2103849796
Cited by
25
References
22
Citations by year
2024: 1 · 2023: 1 · 2022: 2 · 2018: 4 · 2017: 4 · 2016: 2 · 2015: 3 · 2014: 7
FWCI
2.56
Type
journal article
Language
en
Open access
closed
Locations
  • The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
Keywords
growth hormone replacement therapy, acromegaly, growth hormone deficiency, recombinant human growth hormone, quality of life, insulin-like growth factor I, lipid profile, glucose tolerance, insulin resistance, body composition, hypopituitarism, non-functioning pituitary adenoma
MeSH terms
Acromegaly, Adult, Blood Glucose, Female, Humans, Insulin-Like Growth Factor I, Lipids, Male, Middle Aged, Prospective Studies, Quality of Life, Recombinant Proteins, Treatment Outcome, Human Growth Hormone, Hormone Replacement Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GH Replacement Improves Quality of Life and Metabolic Parameters in Cured Acromegalic Patients with Growth Hormone Deficiency. https://app.cochat.ai/papers/10.1210/jc.2012-2477
The paper
Giavoli, C., Profka, E., Verrua, E., Ronchi, C. L., Ferrante, E., Bergamaschi, S., Sala, E., Malchiodi, E., Lania, A. G., Arosio, M., Ambrosi, B., Spada, A., & Beck-Peccoz, P. (2012). GH Replacement Improves Quality of Life and Metabolic Parameters in Cured Acromegalic Patients with Growth Hormone Deficiency. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2012-2477

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.